Markets:

Overview

News

Currencies

International

Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

95.73 -0.11 (-0.12%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 10, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

70 71 Next >

7 Stocks to Sell Right Now… and 1 to Buy ↗

November 18, 2022

Although red ink can sometimes bring an opportunity for contrarianism, these (except one) market ideas represent stocks to sell.

Via InvestorPlace

Pfizer/BioNTech's Omicron Tailored COVID-19 Vaccine Shows Improved Immune Response Against Emerging Omicron Sublineages ↗

November 18, 2022

Via Benzinga

Market Rally Holds Key Levels, But Breakouts Struggle; Walmart, Target, Nvidia In Focus: Weekly Review ↗

November 18, 2022

Walmart, Target and Nvidia were key earnings movers.

Via Investor's Business Daily

Pfizer and BioNTech Report New Data on Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Improved Immune Response Against Emerging Omicron Sublineages

November 18, 2022

From BioNTech SE

Via GlobeNewswire

This COVID-19 Vaccine Stock Has More to Offer ↗

November 10, 2022

The vaccine revenue was nice, but it's time to look ahead.

Via The Motley Fool

Pfizer, BioNTech Take Next Step Toward A Pan-Covid Vaccine — But Is The Demand There? ↗

November 17, 2022

The biggest question facing the shot is whether there will be demand for it.

Via Investor's Business Daily

Ukraine Asserts It Does Not Take Blame For Poland Missile Attack, Crypto Exchange Gemini Suffers $485M In Outflows, FTX, Bahamas Regulator Lock Horns Over Control Of Bankruptcy Proceedings: Top Stories Thursday, Nov. 17 ↗

November 17, 2022

CNBC

Via Benzinga

Pfizer, BioNTech Start Work On Next-Gen COVID-19 Vaccine Candidate For Broader Protection ↗

November 17, 2022

Via Benzinga

Pfizer and BioNTech Advance Next-Generation COVID-19 Vaccine Strategy with Study Start of Candidate Aimed at Enhancing Breadth of T cell Responses and Duration of Protection

November 16, 2022

From BioNTech SE

Via GlobeNewswire

BioNTech SE (BNTX) Q3 2022 Earnings Call Transcript ↗

November 07, 2022

BNTX earnings call for the period ending September 30, 2022.

Via The Motley Fool

While COVID-19 Drags On, Biotechs Introduce New Treatments & Vaccines to Combat Subvariants

November 16, 2022

EQNX::TICKER_START (OTCQB:BIXT),(NASDAQ:NVAX),(NYSE:PFE),(NASDAQ:MRNA),(NASDAQ:INO),(NASDAQ:BNTX) EQNX::TICKER_END

Via FinancialNewsMedia

Third COVID-19 Booster or Fifth Dose Not Required Despite Surge In Cases, Australian Health Authorities Say ↗

November 15, 2022

Australian health authorities have recommended against a fifth COVID-19 vaccine shot despite average daily cases having been 47% higher last week than the week before, said Health Minister Mark Butler...

Via Benzinga

Moderna Surges On New Omicron Data, Pulling Pfizer, BioNTech Along For The Ride ↗

November 14, 2022

Its booster led to a 15.1-fold increase in BA.4- and BA.5-blocking antibodies.

Via Investor's Business Daily

Biotech Sector Gaining Wins Against Pancreatic Cancer with Early Detection and New Therapies

November 14, 2022

FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 14, 2022 – USA News Group – English actor, comedian and Monty Python alumnus Eric Idle credits early detection for his...

Via FinancialNewsMedia

BioNTech Plans To Set Up Singapore Based mRNA Plant By End Of 2023 ↗

November 14, 2022

Via Benzinga

BioNTech Expands Global Footprint by Acquiring GMP Manufacturing Site to Establish First mRNA Facility in Singapore

November 13, 2022

From BioNTech SE

Via GlobeNewswire

Repeat COVID-19 Infection Increases Risk Of Acute Outcomes, Long COVID Symptoms, Study Shows ↗

November 11, 2022

Via Benzinga

Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?

November 10, 2022

By Ernest Dela Aglanu, Benzinga

Via News Direct

Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?

November 10, 2022

Learn more about Organicell Regenerative Medicine, Inc.from this latest report.

Via TheNewswire.com

Europe Approves Sanofi, GSK's Beta Variant Adapted COVID Shot As Booster ↗

November 10, 2022

Via Benzinga

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Children 5 Through 11 Years of Age in European Union

November 10, 2022

From BioNTech SE

Via GlobeNewswire

2 Top Healthcare Stocks to Buy Right Now ↗

November 10, 2022

These two dividend stocks offer 3%-plus dividend yields that are secure.

Via The Motley Fool

Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier? ↗

November 10, 2022

During the peak of the deadly COVID-19 pandemic, one novel therapeutic that seems to have played an important role in helping save lives was Organicell Regenerative Medicine Inc.’s (OTCMKTS:...

Via Benzinga

Return To Office: Pfizer To Enforce 2-3 Days In Office Starting January ↗

November 09, 2022

Pfizer Inc's (NYSE: PFE) CEO Albert Bourla said the U.S. employees would have to return to their workplaces two to three days a week starting in January.

Via Benzinga

The 7 Best Pharma Stocks to Buy Now ↗

November 08, 2022

Investors searching for gains in the current market storm should consider taking a position in some of the best pharma stocks.

Via InvestorPlace

Got $2,000? 2 Fantastic Stocks to Buy No Matter What the Market Does Next ↗

November 08, 2022

These stocks both have non-cyclical businesses that can drive growth in a wide variety of markets.

Via The Motley Fool

BioNTech Takes A Hit Despite Doubling Profit Views, Raising 2022 Outlook ↗

November 07, 2022

BioNTech doubled profit expectations in the third quarter and raised its outlook.

Via Investor's Business Daily

Meta Goes Twitter Way With Layoffs, Twitter Might Want Some People Back After Firing Them, Coal Miners Terminate $6B Combination Discussions: Top Stories Monday, Nov. 07 ↗

November 07, 2022

Wall Street Journal

Via Benzinga

BioNTech Posts About 50% Drop In Q3 Sales and Profits Amid Falling Demand For COVID-19 Shots ↗

November 07, 2022

Via Benzinga

Risk Appetites Survive China Keeping Zero COVID Policy ↗

November 07, 2022

Chinese officials denied plans to end the zero-COVID policy and after a brief wobble, risk assets have traded better. Asia Pacific equities rallied, led by Hong Kong and mainland stocks that trade in...

Via Talk Markets

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

70 71 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.